Trial Profile
First-in-man study to evaluate safety, tolerability and pharmacokinetics of BAY 85-8501 in healthy male subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2015
Price :
$35
*
At a glance
- Drugs PHP 303 (Primary)
- Indications Bronchiectasis
- Focus Adverse reactions; First in man; Pharmacokinetics
- 11 Nov 2015 New trial record